Penumbra Inc.
Penumbra, Inc. Announces Voting Results from Annual Meeting of Stockholders
Summary
Penumbra, Inc. held its Annual Meeting of Stockholders on June 5, 2024, where shareholders voted on three proposals. All three nominees for Class III Directors were elected. The ratification of PricewaterhouseCoopers LLP as the independent public accounting firm for fiscal year 2024 was approved. Additionally, the compensation of the Company's named executive officers was approved on an advisory basis.
Profitelligence Alerts
Get alerts for PEN
Be first to know when Penumbra Inc. files with the SEC.
Filing Categories
Advertisement
About Penumbra Inc.
Penumbra Inc. is a prominent player in the healthcare sector, focusing primarily on the development and commercialization of innovative medical devices. Known for its customer-centric approach, the company operates within the specialized field of interventional therapies, particularly in neuro and vascular medical devices. Penumbra’s products are crucial for addressing critical conditions such as stroke and peripheral artery diseases. By pioneering minimally invasive solutions, the company significantly contributes to enhancing patient outcomes and reshaping intervention methods in the medical field. Founded in 2004 and headquartered in Alameda, California, Penumbra plays a vital role in the medical device industry with its commitment to advancing healthcare technologies. Its solutions are not only pivotal in specialized medical procedures but also support the healthcare ecosystem's broader objective of improving care and saving lives, making it a key entity amongst healthcare providers and hospitals worldwide.
Official SEC Documents
Advertisement